Precision Biosensor News Today

CHICAGO, Sept. 6, 2022 /PRNewswire/ -- Veterinary Diagnostics Market is projected to grow from USD 2.8 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of 9.2% from 2022 to 2027, according

/PRNewswire/ -- Veterinary Diagnostics Market is projected to grow from USD 2.8 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of 9.2% from 2022 to...

Veterinary Infectious Disease Diagnostics Market : Analysis of Potential Opportunity Worth USD 2.6 billion by 2026 in Medical Industry

Veterinary Infectious Disease Diagnostics Market : Analysis of Potential Opportunity Worth USD 2.6 billion by 2026 in Medical Industry

The major factors driving the growth of the veterinary infectious disease diagnostics include the growing demand for rapid tests, rising technological...

/PRNewswire/ -- According to the new market research report "Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular...

/PRNewswire/ -- According to the new market research report "Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular...

Yulchon LLC and Government Contractors Association Int’l with Korea SME’s and startups agency is hosting the Online Global Procurement Opportunities Conference.

Yulchon LLC and Government Contractors Association with Korea SME’s and startups agency (KOSME) hosts Online Global Procurement Opportunities Conference

Posted : 2020-12-23 16:57 By Anna J. Park Microbiome- focused biopharmaceutical firm Genome & Company made its first-day debut on the nations heavy-tech KOSDAQ market Wednesday, transferring its listing from the KONEX market ― the bourse market for venture startups and small- and medium-sized enterprises ― where its stocks had been traded since December 2018. Since its listing at KONEX two years ago, Genome & Company grew to be the markets top company in terms of market cap, with about 741...